Abstract Body

Nearly half of broadly neutralizing antibodies (bnAbs) are polyreactive and/or autoreactive (poly/autoreactive). Some of them, like CH103, gain poly/autoreactivity during bnAb maturation. However, whether poly/autoreactivity and broad neutralization are governed by the same mutations during bnAb maturation is not well understood.

Mutations in Ab pairs differing in poly/autoreactivity within the CH103 lineage were individually introduced back into the Ab from each pair with less (or no) poly/autoreactivity. Recombinant Abs were expressed and purified from transfected Expi293 cells. Neutralization activity against HIV-1 was determined using the TZM-bl assay. Poly/autoreactivity was analyzed by their ability to bind HEp-2 cells, host proteins and UBE3A. Positions and properties of mutations were analyzed using Swiss-Model.

Poly/autoreactivity became detectable for intermediate antibody 1 (IA1) and mature bnAbs during evolution of the CH103 lineage. There were 2, 17 and 11 amino acid (aa) differences between IA2/IA1, IA3/IA1, and CH103/CH106 Abs, respectively. Each of these aa differences was introduced into the Abs without (IA2 or IA3) or weak (CH103) poly/autoreactivity, and they had little effects on neutralization. The IA2 variable heavy (VH) N60S mutant Ab and the CH103 VH E56H mutant Ab reacted to HEp-2 and many host proteins and dsDNA, while the IA2 VH E64K mutant Ab was only reactive to histone. The protein array analysis using ~9000 human proteins showed that the IA2 N60S mutant Ab is poly/autoreactive, while the E64K mutation did not render IA2 poly/autoreactive. The UBE3A binding analysis of all mutants showed that only the VH E64K mutation in IA2 and IA3 as well as the VH E56H and VL E45D mutations in CH103 rendered their parental Abs reactive to UBE3A. Structure modeling showed all those mutations were in VH CDR2 or upstream of VL CDR2 but the aa substitutions were not thought to affect binding to HIV-1 Env. However, aa charge changes in the VH and VL CDR2 regions may play an important role in increased poly/autoreactivity.  

Development of poly/autoreactivity during maturation of the bnAb CH103 lineage is determined by several somatic mutations not required for developing broad neutralization. The charge changes in the CDR2 regions of VH and VL mini-genes may play an especially important role in specifying poly/autoreactivity in this bnAb lineage.